메뉴 건너뛰기




Volumn 29, Issue 5, 2010, Pages 415-420

A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin b for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia

(17)  Maertens, Johan A a   Madero, Luis b   Reilly, Anne F c   Lehrnbecher, Thomas d   Groll, Andreas H e   Jafri, Hasan S f   Green, Michael g   Nania, Joseph J h   Bourque, Michael R i   Wise, Beth Ann i   Strohmaier, Kim M i   Taylor, Arlene F i   Kartsonis, Nicholas A i   Chow, Joseph W i   Arndt, Carola A S j   Depauw, Ben E k   Walsh, Thomas J l  


Author keywords

Caspofungin; Empiric antifungal therapy; Fever and neutropenia; Liposomal amphotericin B; Pediatric patients

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; CASPOFUNGIN; PLACEBO; VORICONAZOLE;

EID: 77951874577     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181da2171     Document Type: Article
Times cited : (129)

References (36)
  • 1
    • 14744278435 scopus 로고    scopus 로고
    • Perspectives for the management of febrile neutropenic patients with cancer in the 21st century
    • Sipsas NV, Bodey GP, Kontoyiannis DP. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer. 2005;103:1103-1113.
    • (2005) Cancer , vol.103 , pp. 1103-1113
    • Sipsas, N.V.1    Bodey, G.P.2    Kontoyiannis, D.P.3
  • 2
    • 33645302916 scopus 로고    scopus 로고
    • Current approaches to diagnosis and treatment of invasive aspergillosis
    • Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med. 2006;173:707-717.
    • (2006) Am J Respir Crit Care Med , vol.173 , pp. 707-717
    • Segal, B.H.1    Walsh, T.J.2
  • 3
    • 0037087226 scopus 로고    scopus 로고
    • 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
    • Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730-751.
    • (2002) Clin Infect Dis. , vol.34 , pp. 730-751
    • Hughes, W.T.1    Armstrong, D.2    Bodey, G.P.3
  • 4
    • 0032888684 scopus 로고    scopus 로고
    • Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival
    • Groll AH, Kurz M, Schneider W, et al. Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival. Mycoses. 1999;42:431-442.
    • (1999) Mycoses , vol.42 , pp. 431-442
    • Groll, A.H.1    Kurz, M.2    Schneider, W.3
  • 5
    • 0033512462 scopus 로고    scopus 로고
    • Aspergillosis in children with cancer: A 34-year experience
    • Abbasi S, Shenep JL, Hughes WT, et al. Aspergillosis in children with cancer: a 34-year experience. Clin Infect Dis. 1999;29:1210-1219.
    • (1999) Clin Infect Dis , vol.29 , pp. 1210-1219
    • Abbasi, S.1    Shenep, J.L.2    Hughes, W.T.3
  • 6
    • 0033757977 scopus 로고    scopus 로고
    • Invasive fungal infections in pediatric bone marrow transplant recipients: Single center experience of 10 years
    • Hovi L, Saarinen-Pihkala UM, Vettenranta K, et al. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant. 2000;26:999-1004.
    • (2000) Bone Marrow Transplant , vol.26 , pp. 999-1004
    • Hovi, L.1    Saarinen-Pihkala, U.M.2    Vettenranta, K.3
  • 7
    • 0033847078 scopus 로고    scopus 로고
    • Prospective study on fungemia in children with cancer: Analysis of 35 cases and comparison with 130 fungemias in adults
    • Krupova Y, Sejnova D, Dzatkova J, et al. Prospective study on fungemia in children with cancer: analysis of 35 cases and comparison with 130 fungemias in adults. Support Care Cancer. 2000;8:427-430.
    • (2000) Support Care Cancer , vol.8 , pp. 427-430
    • Krupova, Y.1    Sejnova, D.2    Dzatkova, J.3
  • 8
    • 1542327728 scopus 로고    scopus 로고
    • Candida infections in children treated with conventional chemotherapy for solid tumors (transplant recipients excluded): The Institut Gustave Roussy Pediatrics Department experience
    • Ridola V, Chachaty E, Raimondo G, et al. Candida infections in children treated with conventional chemotherapy for solid tumors (transplant recipients excluded): the Institut Gustave Roussy Pediatrics Department experience. Pediatr Blood Cancer. 2004;42:332-337.
    • (2004) Pediatr Blood Cancer , vol.42 , pp. 332-337
    • Ridola, V.1    Chachaty, E.2    Raimondo, G.3
  • 9
    • 0038613711 scopus 로고    scopus 로고
    • Nonalbicans candida is the most common cause of candidemia in pediatric cancer patients
    • Mullen CA, Abd El-Baki H, Samir H, et al. Nonalbicans candida is the most common cause of candidemia in pediatric cancer patients. Support Care Cancer. 2003;11:321-325.
    • (2003) Support Care Cancer , vol.11 , pp. 321-325
    • Mullen, C.A.1    Abd El-Baki, H.2    Samir, H.3
  • 10
    • 15444375213 scopus 로고    scopus 로고
    • Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution
    • Rosen GP, Nielsen K, Glenn S, et al. Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution. J Pediatr Hematol Oncol. 2005;27:135-140.
    • (2005) J Pediatr Hematol Oncol , vol.27 , pp. 135-140
    • Rosen, G.P.1    Nielsen, K.2    Glenn, S.3
  • 11
    • 30944451379 scopus 로고    scopus 로고
    • Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic he-matopoietic cell transplantation
    • Dvorak CC, Steinbach WJ, Brown JM, et al. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic he-matopoietic cell transplantation. Bone Marrow Transplant. 2005;36:621-629.
    • (2005) Bone Marrow Transplant , vol.36 , pp. 621-629
    • Dvorak, C.C.1    Steinbach, W.J.2    Brown, J.M.3
  • 12
    • 33745698978 scopus 로고    scopus 로고
    • Fungal infections in children with cancer: A prospective, multicenter surveillance study
    • Castagnola E, Cesaro S, Giacchino M, et al. Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J. 2006;25:634-639.
    • (2006) Pediatr Infect Dis J , vol.25 , pp. 634-639
    • Castagnola, E.1    Cesaro, S.2    Giacchino, M.3
  • 14
    • 9844239388 scopus 로고    scopus 로고
    • A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients
    • Prentice HG, Hann IM, Herbrecht R, et al. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol. 1997;98:711-718.
    • (1997) Br J Haematol , vol.98 , pp. 711-718
    • Prentice, H.G.1    Hann, I.M.2    Herbrecht, R.3
  • 17
    • 0028140216 scopus 로고
    • Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: The potential role of bronchoalveolar lavage D-mannitol and galactomannan as markers of infection
    • Francis P, Lee JW, Hoffman A, et al. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar lavage D-mannitol and galactomannan as markers of infection. J Infect Dis. 1994;169:356-368.
    • (1994) J Infect Dis , vol.169 , pp. 356-368
    • Francis, P.1    Lee, J.W.2    Hoffman, A.3
  • 18
    • 0028988695 scopus 로고
    • Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data
    • Ng TT, Denning DW. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data. Arch Intern Med. 1995;155:1093-1098.
    • (1995) Arch Intern Med , vol.155 , pp. 1093-1098
    • Ng, T.T.1    Denning, D.W.2
  • 19
    • 17044455920 scopus 로고    scopus 로고
    • In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743 872)
    • Bartizal K, Gill CJ, Abruzzo GK, et al. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimi-crob Agents Chemother. 1997;41:2326-2332.
    • (1997) Antimi-crob Agents Chemother , vol.41 , pp. 2326-2332
    • Bartizal, K.1    Gill, C.J.2    Abruzzo, G.K.3
  • 20
    • 0033836270 scopus 로고    scopus 로고
    • Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclo-phosphamide-induced immunosuppressed mice
    • Abruzzo GK, Gill CJ, Flattery AM, et al. Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclo-phosphamide-induced immunosuppressed mice. Antimicrob Agents Chemother. 2000;44:2310-2318.
    • (2000) Antimicrob Agents Chemother , vol.44 , pp. 2310-2318
    • Abruzzo, G.K.1    Gill, C.J.2    Flattery, A.M.3
  • 21
    • 0036135430 scopus 로고    scopus 로고
    • Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: Pharmacokinetics, drug disposition and relationship to galactomannan antigenemia
    • Petraitiene R, Petraitis V, Groll AH, et al. Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition and relationship to galactomannan antigenemia. Antimicrob Agents Chemother. 2002;46:12-23.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 12-23
    • Petraitiene, R.1    Petraitis, V.2    Groll, A.H.3
  • 22
    • 0033545538 scopus 로고    scopus 로고
    • Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group
    • Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med. 1999;340:764-771.
    • (1999) N Engl J Med , vol.340 , pp. 764-771
    • Walsh, T.J.1    Finberg, R.W.2    Arndt, C.3
  • 23
    • 4644346490 scopus 로고    scopus 로고
    • Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
    • Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 2004;351:1391-1402.
    • (2004) N Engl J Med , vol.351 , pp. 1391-1402
    • Walsh, T.J.1    Teppler, H.2    Donowitz, G.R.3
  • 24
    • 0036133373 scopus 로고    scopus 로고
    • Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
    • Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7-14.
    • (2002) Clin Infect Dis , vol.34 , pp. 7-14
    • Ascioglu, S.1    Rex, J.H.2    De Pauw, B.3
  • 26
    • 0033972985 scopus 로고    scopus 로고
    • A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer
    • Winston DJ, Hathorn JW, Schuster MG, et al. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer. Am J Med. 2000;108:282-289.
    • (2000) Am J Med , vol.108 , pp. 282-289
    • Winston, D.J.1    Hathorn, J.W.2    Schuster, M.G.3
  • 27
    • 33645726603 scopus 로고    scopus 로고
    • Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: Analysis of results from the Caspofungin Empirical Therapy Study
    • de Pauw BE, Sable CA, Walsh TJ, et al. Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study. Transpl Infect Dis. 2006;8:31-37.
    • (2006) Transpl Infect Dis , vol.8 , pp. 31-37
    • De Pauw, B.E.1    Sable, C.A.2    Walsh, T.J.3
  • 29
    • 27644585388 scopus 로고    scopus 로고
    • Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents
    • Walsh TJ, Adamson PC, Seibel NL, et al. Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob Agents Chemother. 2005;49:4536-4545.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 4536-4545
    • Walsh, T.J.1    Adamson, P.C.2    Seibel, N.L.3
  • 30
    • 34248160575 scopus 로고    scopus 로고
    • Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
    • Cornely OA, Maertens J, Bresnik M, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007;44:1289-1297.
    • (2007) Clin Infect Dis , vol.44 , pp. 1289-1297
    • Cornely, O.A.1    Maertens, J.2    Bresnik, M.3
  • 31
    • 32644466027 scopus 로고    scopus 로고
    • Treatment with caspofungin in immunocompromised paediatric patients: A multicentre survey
    • Groll AH, Attarbaschi A, Schuster FR, et al. Treatment with caspofungin in immunocompromised paediatric patients: a multicentre survey. J Antimicrob Chemother. 2006;57:527-535.
    • (2006) J Antimicrob Chemother , vol.57 , pp. 527-535
    • Groll, A.H.1    Attarbaschi, A.2    Schuster, F.R.3
  • 32
    • 63149172257 scopus 로고    scopus 로고
    • A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients
    • Zaoutis T, Jafri H, Huang L, et al. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Pediatrics. 2009;123:877-884.
    • (2009) Pediatrics , vol.123 , pp. 877-884
    • Zaoutis, T.1    Jafri, H.2    Huang, L.3
  • 33
    • 0031684378 scopus 로고    scopus 로고
    • Chest discomfort associated with liposomal amphotericin B: Report of three cases and review of the literature
    • Johnson MD, Drew RH, Perfect JR. Chest discomfort associated with liposomal amphotericin B: report of three cases and review of the literature. Pharmacotherapy. 1998;18:1053-1061.
    • (1998) Pharmacotherapy , vol.18 , pp. 1053-1061
    • Johnson, M.D.1    Drew, R.H.2    Perfect, J.R.3
  • 34
    • 0038183841 scopus 로고    scopus 로고
    • A triad of acute infusion-related reactions associated with liposomal amphotericin B: Analysis of clinical and epidemiological characteristics
    • Roden MM, Nelson LD, Knudsen TA, et al. A triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics. Clin Infect Dis. 2003;36:1213-1220.
    • (2003) Clin Infect Dis , vol.36 , pp. 1213-1220
    • Roden, M.M.1    Nelson, L.D.2    Knudsen, T.A.3
  • 35
    • 0042349758 scopus 로고    scopus 로고
    • Effects of amphotericin B and caspofungin on histamine expression
    • Cleary JD, Schwartz M, Rogers PD, et al. Effects of amphotericin B and caspofungin on histamine expression. Pharmacotherapy. 2003;23:966-973.
    • (2003) Pharmacotherapy , vol.23 , pp. 966-973
    • Cleary, J.D.1    Schwartz, M.2    Rogers, P.D.3
  • 36
    • 49449103740 scopus 로고    scopus 로고
    • Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria
    • Segal BH, Herbrecht R, Stevens DA, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008;47:674-683.
    • (2008) Clin Infect Dis , vol.47 , pp. 674-683
    • Segal, B.H.1    Herbrecht, R.2    Stevens, D.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.